¿El fin del concepto de irreversibilidad? | 15 SEP 17

Una nueva categoría: "diabetes en remisión"

Reconocer y codificar con precisión la reversión de la diabetes tipo 2 es clave para mejorar los resultados y reducir los costos de atención médica
Autor/a: Louise McCombie, researcher, Wilma Leslie, researcher, Roy Taylor, professor, Brian Kennon, Naveed Sattar, professor , Mike E J Lean, professor Fuente: BMJ 2017;358:j4030 Beating type 2 diabetes into remission
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas
  1. Diabetes UK. Cost of diabetes report. 2014, https://www.diabetes.org.uk/Documents/Diabetes UK Cost of Diabetes Report.pdf
  2. Wright AK, Kontopantelis E, Emsley R, et al. Life expectancy and cause-specific mortality in type 2 diabetes: a population-based cohort study quantifying relationships in ethnic subgroups. Diabetes Care2017;358:338-45.
  3. Leslie WS, Ford I, Sattar N, et al. The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial. BMC Fam Pract2016;358:20. doi:10.1186/s12875-016-0406-2 pmid:26879684.
  4. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.Lancet2015;358:964-73. doi:10.1016/S0140-6736(15)00075-6 pmid:26369473.
  5. Medtrak. Anti-diabetes medications in US and Europe, April 2017.
  6. Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia2011;358:2506-14. doi:10.1007/s00125-011-2204-7 pmid:21656330.
  7. Steven S, Hollingsworth KG, Al-Mrabeh A, et al. Very low-calorie diet and 6 months of weight stability in type 2 diabetes: pathophysiological changes in responders and nonresponders. Diabetes Care2016;358:808-15. doi:10.2337/dc15-1942 pmid:27002059.
  8. Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes?Diabetes Care2009;358:2133-5.doi:10.2337/dc09-9036 pmid:19875608.
  9. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med2009;358:248-256.e5. doi:10.1016/j.amjmed.2008.09.041 pmid:19272486.
  10. Gregg EW, Chen H, Wagenknecht LE, et al. Look AHEAD Research Group. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA2012;358:2489-96. doi:10.1001/jama.2012.67929 pmid:23288372.
  11. Tancredi M, Rosengren A, Svensson AM, et al. Excess mortality among persons with type 2 diabetesN Engl J Med2015;358:1720-32. doi:10.1056/NEJMoa1504347 pmid:26510021.
  12. Zoungas S, Arima H, Gerstein HC, et al. Collaborators on Trials of Lowering Glucose (CONTROL) group. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials. Lancet Diabetes Endocrinol2017;358:431-7. doi:10.1016/S2213-8587(17)30104-3pmid:28365411.
  13. Romeo S, Maglio C, Burza MA, et al. Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes.Diabetes Care2012;358:2613-7. doi:10.2337/dc12-0193 pmid:22855732.
  14. Karter AJ, Nundy S, Parker MM, Moffet HH, Huang ES. Incidence of remission in adults with type 2 diabetes: the diabetes & aging study. Diabetes Care2014;358:3188-95. doi:10.2337/dc14-0874 pmid:25231895.
  15. General Medical Services. Quality and Outcomes Framework (QOF) guidance for GMS contract 2016/17. 2016.http://www.nhsemployers.org/~/media/Employers/Documents/Primary%20care%20contracts/QOF/2016-17/2016-17%20QOF%20guidance%20documents.pdf
  16. Lean M, Brosnahan N, McLoone P, et al. Feasibility and indicative results from a 12-month low-energy liquid diet treatment and maintenance programme for severe obesity. Br J Gen Pract2013;358:e115-24.doi:10.3399/bjgp13X663073 pmid:23561690.
  17. Johansson K, Neovius M, Hemmingsson E. Effects of anti-obesity drugs, diet, and exercise on weight-loss maintenance after a very-low-calorie diet or low-calorie diet: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr2014;358:14-23. doi:10.3945/ajcn.113.070052 pmid:24172297.
  18. Logue J, Thompson L, Romanes F, Wilson DC, Thompson J, Sattar N. Guideline Development Group. Management of obesity: summary of SIGN guideline. BMJ2010;358:c154.doi:10.1136/bmj.c154 pmid:20181637.
  19. Rehackova L, Araújo-Soares V, Adamson AJ, Steven S, Taylor R, Sniehotta FF. Acceptability of a very-low-energy diet in Type 2 diabetes: patient experiences and behaviour regulation. Diabet Med2017. doi:10.1111/dme.13426pmid:28727247.
  20. Dall TM, Zhang Y, Chen YJ, Quick WW, Yang WG, Fogli J. The economic burden of diabetes. Health Aff (Millwood)2010;358:297-303. doi:10.1377/hlthaff.2009.0155 pmid:20075080.
  21. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States 2011. US Department of Health and Human Services, Centers for Disease Control and Prevention, 2011.
  22. American Diabetes Association. Living with diabetes, health insurance. http://www.diabetes.org/living-with-diabetes/health-insurance/medicare.html?referrer=https://www.google.co.uk/
  23. Stark Casagrande S, Cowie CC. Health insurance coverage among people with and without diabetes in the US adult population.Diabetes Care2012;358:2243-9.


Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí

Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2020